Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlin Chemie AgfiledCriticalBerlin Chemie Ag
Publication of AR110957A1publicationCriticalpatent/AR110957A1/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Se describe un agente terapéutico oral para tiroides, que comprende levotiroxina o sus sales farmacéuticamente aceptables como ingrediente activo, en combinación con por lo menos un agente antioxidante y por lo menos un agente adsorbente, en donde la proporción expresada en % en peso de ingrediente activo : agente antioxidante : agente adsorbente es entre 1:1:5 y 1:50:100.An oral therapeutic agent for thyroid is described, comprising levothyroxine or its pharmaceutically acceptable salts as active ingredient, in combination with at least one antioxidant agent and at least one adsorbent agent, wherein the proportion expressed in weight% of active ingredient. : antioxidant agent: adsorbent agent is between 1: 1: 5 and 1: 50: 100.
ARP180100259A2017-02-032018-02-02
ORAL THERAPEUTIC AGENT FOR THYROID
AR110957A1
(en)
Ingestible soft capsule containing inositol and excipients, or inositol, excipients and at least one additional active substance, such as folic acid, cocoa polyphenols, genistein, l-arginine, vitamin E, selenium, n-acetylcysteine and melatonin; useful for the treatment of polycystic ovary, insulin resistance and others